Clinical Trials in Portland

Showing 6401-6420 of 10,048 trials

The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation

NCT01129245

The purpose of this study is to assess the effect that Celebrex (a COX-2 inhibitor and non-steroidal anti-inflammatory drug) has on ovulation.

OvulationLuteal Development

Oregon Health and Science University20 participantsStarted Sep 2009

Portland, Oregon, United States

COMPLETEDPhase 1/2< 1 mile

Testing of the Apnea Prevention Device

NCT00875134

This study is designed to test the ability of a computer-based algorithm to detect and intervene in cases of narcotic-induced respiratory depression.

Respiratory DepressionElective Surgery

Oregon Health and Science University30 participantsStarted Mar 2009

Portland, Oregon, United States

COMPLETED< 1 mile

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

NCT02225041

The purpose of this study is to determine the relationships between sedative exposure during pediatric critical illness and long-term neurocognitive outcomes. We will test for drug- and dose-dependent relationships between sedative exposure and neurocognitive outcomes along the early developmental spectrum and will control for baseline and environmental factors, as well as the severity and course of illness. Hypotheses: 1. Greater exposure to benzodiazepines and/or ketamine will be associated with lower IQ even when controlling for severity of illness, hospital course, and baseline factors. In addition, benzodiazepines and/or ketamine will negatively affect other aspects of neurocognitive function. 2. Younger children exposed to benzodiazepines and/or ketamine will have worse neurocognitive outcomes than older children with similar sedative exposure and severity of illness.

Intellectual DisabilityPerceptual DisordersMemory Disorders

University of Pennsylvania360 participantsStarted Aug 2014

Birmingham, Alabama, United States • Tucson, Arizona, United States • Oakland, California, United States +28 more locations

The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation

Testing of the Apnea Prevention Device

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

Find Trials by Condition in Portland

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry

The Influence of Probiotics on Vancomycin-Resistant Enterococcus

Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Effects of High Flow Nasal Cannula on Deadspace Reduction and Regional Distribution of Ventilation

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Phase II Trial of Erlotinib in Advanced Pancreatic Cancer

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy